161 related articles for article (PubMed ID: 15884118)
61. Clarithromycin or amoxycillin plus high-dose ranitidine in the treatment of Helicobacter pylori-positive functional dyspepsia.
Schütze K; Hentschel E; Hirschl AM
Eur J Gastroenterol Hepatol; 1996 Jan; 8(1):41-6. PubMed ID: 8900907
[TBL] [Abstract][Full Text] [Related]
62. In dyspeptic patients without gastric phase III of the migrating motor complex, Helicobacter pylori eradication produces no short-term changes in interdigestive motility pattern.
Testoni PA; Bagnolo F
Scand J Gastroenterol; 2000 Aug; 35(8):808-13. PubMed ID: 10994618
[TBL] [Abstract][Full Text] [Related]
63. [Helicobacter pylori-related diseases: dyspepsia, ulcer and gastric cancer].
Gisbert JP
Gastroenterol Hepatol; 2008 Oct; 31 Suppl 4():18-28. PubMed ID: 19434862
[TBL] [Abstract][Full Text] [Related]
64. [Helicobacter pylori and Arteriosclerosis].
Matsui T
Gan To Kagaku Ryoho; 2011 Mar; 38(3):365-9. PubMed ID: 21403439
[TBL] [Abstract][Full Text] [Related]
65. Could gastric histology be a useful marker for making decision on Helicobacter pylori eradication therapy in patients with dyspepsia?
Arruda SM; Forones NM; Jucá NT; de Barros KS
Arq Gastroenterol; 2009; 46(3):209-13. PubMed ID: 19918688
[TBL] [Abstract][Full Text] [Related]
66. Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study.
Toyokawa T; Suwaki K; Miyake Y; Nakatsu M; Ando M
J Gastroenterol Hepatol; 2010 Mar; 25(3):544-7. PubMed ID: 19817964
[TBL] [Abstract][Full Text] [Related]
67. Symptom-based tendencies of Helicobacter pylori eradication in patients with functional dyspepsia.
Lan L; Yu J; Chen YL; Zhong YL; Zhang H; Jia CH; Yuan Y; Liu BW
World J Gastroenterol; 2011 Jul; 17(27):3242-7. PubMed ID: 21912474
[TBL] [Abstract][Full Text] [Related]
68. Preoperative versus postoperative Helicobacter pylori eradication therapy in gastric cancer patients: a randomized trial.
Kim CG; Song HJ; Kook MC; Hong EK; Park S; Lee JY; Lee JH; Ryu KW; Kim YW; Bae JM; Choi IJ
Am J Gastroenterol; 2008 Jan; 103(1):48-54. PubMed ID: 17714557
[TBL] [Abstract][Full Text] [Related]
69. Development of plasma ghrelin level as a novel marker for gastric mucosal atrophy after
Mori H; Suzuki H; Matsuzaki J; Kameyama K; Igarashi K; Masaoka T; Kanai T
Ann Med; 2022 Dec; 54(1):170-180. PubMed ID: 35000515
[TBL] [Abstract][Full Text] [Related]
70. Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
Uygun A; Kadayifçi A; Yeşilova Z; Savaş MC; Ateş Y; Karslioğlu Y; Ciğerim M; Bağci S; Dağalp K
Turk J Gastroenterol; 2004 Dec; 15(4):219-24. PubMed ID: 16249974
[TBL] [Abstract][Full Text] [Related]
71. One-week therapy with pantoprazole versus ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.
Gisbert JP; Carpio D; Marcos S; Gisbert JL; García Grávalos R; Pajares JM
Eur J Gastroenterol Hepatol; 2000 May; 12(5):489-95. PubMed ID: 10833090
[TBL] [Abstract][Full Text] [Related]
72. Improvement in lipid and haemostasis patterns after Helicobacter pylori infection eradication in type 1 diabetic patients.
de Luis DA; Garcia Avello A; Lasuncion MA; Aller R; Martin de Argila C; Boixeda de Miquel D; de la Calle H
Clin Nutr; 1999 Aug; 18(4):227-31. PubMed ID: 10578022
[TBL] [Abstract][Full Text] [Related]
73. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study.
Kyzekova J; Mour J
Hepatogastroenterology; 1999; 46(27):2048-56. PubMed ID: 10430396
[TBL] [Abstract][Full Text] [Related]
74. Development of corpus atrophic gastritis may be associated with Helicobacter pylori-related idiopathic thrombocytopenic purpura.
Sato R; Murakami K; Okimoto T; Watanabe K; Kodama M; Fujioka T
J Gastroenterol; 2011 Aug; 46(8):991-7. PubMed ID: 21594563
[TBL] [Abstract][Full Text] [Related]
75. Influence of Helicobacter pylori status and eradication on the serum levels of trefoil factors and pepsinogen test: serum trefoil factor 3 is a stable biomarker.
Kaise M; Miwa J; Fujimoto A; Tashiro J; Tagami D; Sano H; Ohmoto Y
Gastric Cancer; 2013 Jul; 16(3):329-37. PubMed ID: 22907485
[TBL] [Abstract][Full Text] [Related]
76. The influence of vitamin D deficiency on eradication rates of Helicobacter pylori.
Yildirim O; Yildirim T; Seckin Y; Osanmaz P; Bilgic Y; Mete R
Adv Clin Exp Med; 2017 Dec; 26(9):1377-1381. PubMed ID: 29442458
[TBL] [Abstract][Full Text] [Related]
77. Evaluation of therapeutic regimens for the treatment of Helicobacter pylori infection.
Lee DH; Park HJ; Song SY; Lee SJ; Choi W; Lee YC; Chung JB; Kang JK; Park IS; Lee YH; Kim HK
Yonsei Med J; 1996 Aug; 37(4):270-7. PubMed ID: 8942297
[TBL] [Abstract][Full Text] [Related]
78. [Effect of eradication treatment on histological changes of the gastric mucosa in patients with non-ulcer dyspesia and Helicobacter pylori infection. Randomized prospective study].
Kyzeková J
Vnitr Lek; 1999 Feb; 45(2):90-6. PubMed ID: 15641227
[TBL] [Abstract][Full Text] [Related]
79. Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori.
Bardhan KD; Morton D; Perry MJ; Sanders DS; Morris P; Rowland A; Thompson M; Mitchell TR; Roberts PM
Aliment Pharmacol Ther; 2001 Aug; 15(8):1199-204. PubMed ID: 11472323
[TBL] [Abstract][Full Text] [Related]
80. Low initial vitamin B12 levels in Helicobacter pylori--positive patients on chronic hemodialysis.
Trimarchi H; Forrester M; Schropp J; Pereyra H; Freixas EA
Nephron Clin Pract; 2004; 96(1):c28-32. PubMed ID: 14752251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
